Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT03220425




Registration number
NCT03220425
Ethics application status
Date submitted
13/07/2017
Date registered
18/07/2017
Date last updated
18/07/2017

Titles & IDs
Public title
Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
Scientific title
A Six Month, Multi-centre, Open-label, Parallel Efficacy and Safety Comparison of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes on a Basal-bolus Regimen.
Secondary ID [1] 0 0
NN304-1335
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Diabetes Mellitus, Type 1 0 0
Condition category
Condition code
Metabolic and Endocrine 0 0 0 0
Diabetes

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Insulin detemir
Treatment: Drugs - NPH insulin

Experimental: Insulin detemir -

Active Comparator: NPH insulin -


Treatment: Drugs: Insulin detemir


Treatment: Drugs: NPH insulin
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
The change in the level of glycosylated haemoglobin(HbA1c)
Timepoint [1] 0 0
From start of treatment visit 2 (week 0) until end of treatment visit 8 (week 26)

Eligibility
Key inclusion criteria
- Signed and dated informed consent obtained before any trial-related activities

- Type 1 diabetes diagnosed and classified according to aetiology

- Duration of type 1 diabetes equal to or more than 12 months

- Glycosylated haemoglobin less than or equal to 12 percent based on analysis from
central laboratory

- Able and willing to perform self-blood glucose monitoring
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Proliferative retinopathy

- Total basal insulin dose of more than 100 IU per day

- Recurrent major hypoglycaemia - that would interfere with trial participation (as
judged by the investigator)

- Known unawareness of hypoglycaemia

- Previous treatment with insulin detemir

Study design
Purpose of the study
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/02/2001
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
12/11/2001
Sample size
Target
Accrual to date
Final
752
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Novo Nordisk Investigational Site - Broadmeadow
Recruitment hospital [2] 0 0
Novo Nordisk Investigational Site - Ashford
Recruitment hospital [3] 0 0
Novo Nordisk Investigational Site - Box Hill
Recruitment hospital [4] 0 0
Novo Nordisk Investigational Site - Clayton
Recruitment hospital [5] 0 0
Novo Nordisk Investigational Site - Garran
Recruitment hospital [6] 0 0
Novo Nordisk Investigational Site - Ringwood
Recruitment hospital [7] 0 0
Novo Nordisk Investigational Site - Stones Corner
Recruitment hospital [8] 0 0
Novo Nordisk Investigational Site - Woodville
Recruitment postcode(s) [1] 0 0
2292 - Broadmeadow
Recruitment postcode(s) [2] 0 0
5035 - Ashford
Recruitment postcode(s) [3] 0 0
3128 - Box Hill
Recruitment postcode(s) [4] 0 0
3168 - Clayton
Recruitment postcode(s) [5] 0 0
2605 - Garran
Recruitment postcode(s) [6] 0 0
3134 - Ringwood
Recruitment postcode(s) [7] 0 0
4120 - Stones Corner
Recruitment postcode(s) [8] 0 0
5011 - Woodville
Recruitment outside Australia
Country [1] 0 0
Belgium
State/province [1] 0 0
Bornem
Country [2] 0 0
Belgium
State/province [2] 0 0
Edegem
Country [3] 0 0
Belgium
State/province [3] 0 0
Gent
Country [4] 0 0
Belgium
State/province [4] 0 0
Leuven
Country [5] 0 0
Belgium
State/province [5] 0 0
Luxembourg
Country [6] 0 0
Denmark
State/province [6] 0 0
Fredericia
Country [7] 0 0
Denmark
State/province [7] 0 0
Frederiksberg
Country [8] 0 0
Denmark
State/province [8] 0 0
Hvidovre
Country [9] 0 0
Denmark
State/province [9] 0 0
København
Country [10] 0 0
Denmark
State/province [10] 0 0
Middelfart
Country [11] 0 0
Denmark
State/province [11] 0 0
Odense
Country [12] 0 0
Denmark
State/province [12] 0 0
Vejle
Country [13] 0 0
Denmark
State/province [13] 0 0
Århus C
Country [14] 0 0
Finland
State/province [14] 0 0
Espoo
Country [15] 0 0
Finland
State/province [15] 0 0
Helsinki
Country [16] 0 0
Finland
State/province [16] 0 0
Joensuu
Country [17] 0 0
Finland
State/province [17] 0 0
Kemi
Country [18] 0 0
Finland
State/province [18] 0 0
Vantaa
Country [19] 0 0
France
State/province [19] 0 0
ANGERS cedex 09
Country [20] 0 0
France
State/province [20] 0 0
Avignon
Country [21] 0 0
France
State/province [21] 0 0
Bondy
Country [22] 0 0
France
State/province [22] 0 0
Corbeil Essonnes
Country [23] 0 0
France
State/province [23] 0 0
LA ROCHELLE cedex
Country [24] 0 0
France
State/province [24] 0 0
Le Creusot
Country [25] 0 0
France
State/province [25] 0 0
MONTPELLIER cedex 5
Country [26] 0 0
France
State/province [26] 0 0
Narbonne
Country [27] 0 0
France
State/province [27] 0 0
NEVERS cedex
Country [28] 0 0
France
State/province [28] 0 0
Paris Cedex 10
Country [29] 0 0
France
State/province [29] 0 0
Paris
Country [30] 0 0
France
State/province [30] 0 0
Poitiers
Country [31] 0 0
France
State/province [31] 0 0
Rennes
Country [32] 0 0
Ireland
State/province [32] 0 0
Dublin
Country [33] 0 0
Netherlands
State/province [33] 0 0
Amersfoort
Country [34] 0 0
Netherlands
State/province [34] 0 0
Apeldoorn
Country [35] 0 0
Netherlands
State/province [35] 0 0
Brunssum
Country [36] 0 0
Netherlands
State/province [36] 0 0
Den Haag
Country [37] 0 0
Netherlands
State/province [37] 0 0
Eindhoven
Country [38] 0 0
Netherlands
State/province [38] 0 0
Haarlem
Country [39] 0 0
Netherlands
State/province [39] 0 0
Hengelo
Country [40] 0 0
Netherlands
State/province [40] 0 0
Utrecht
Country [41] 0 0
Norway
State/province [41] 0 0
Bergen
Country [42] 0 0
Norway
State/province [42] 0 0
Jessheim
Country [43] 0 0
Norway
State/province [43] 0 0
Kongsvinger
Country [44] 0 0
Norway
State/province [44] 0 0
Oslo
Country [45] 0 0
Norway
State/province [45] 0 0
Sarpsborg
Country [46] 0 0
Norway
State/province [46] 0 0
Stavanger
Country [47] 0 0
Norway
State/province [47] 0 0
Stord
Country [48] 0 0
Norway
State/province [48] 0 0
Trondheim
Country [49] 0 0
Sweden
State/province [49] 0 0
Falun
Country [50] 0 0
Sweden
State/province [50] 0 0
Helsingborg
Country [51] 0 0
Sweden
State/province [51] 0 0
Karlstad
Country [52] 0 0
Sweden
State/province [52] 0 0
Lund
Country [53] 0 0
Sweden
State/province [53] 0 0
Skövde
Country [54] 0 0
Sweden
State/province [54] 0 0
Stockholm
Country [55] 0 0
Sweden
State/province [55] 0 0
Umeå
Country [56] 0 0
Sweden
State/province [56] 0 0
Uppsala
Country [57] 0 0
Sweden
State/province [57] 0 0
Värnamo
Country [58] 0 0
Sweden
State/province [58] 0 0
Örebro
Country [59] 0 0
United Kingdom
State/province [59] 0 0
Abergavenny
Country [60] 0 0
United Kingdom
State/province [60] 0 0
Blackburn
Country [61] 0 0
United Kingdom
State/province [61] 0 0
Bolton
Country [62] 0 0
United Kingdom
State/province [62] 0 0
Bristol
Country [63] 0 0
United Kingdom
State/province [63] 0 0
Cosham
Country [64] 0 0
United Kingdom
State/province [64] 0 0
Derby
Country [65] 0 0
United Kingdom
State/province [65] 0 0
Gillingham
Country [66] 0 0
United Kingdom
State/province [66] 0 0
Glasgow
Country [67] 0 0
United Kingdom
State/province [67] 0 0
Guildford
Country [68] 0 0
United Kingdom
State/province [68] 0 0
Kettering
Country [69] 0 0
United Kingdom
State/province [69] 0 0
Livingstone
Country [70] 0 0
United Kingdom
State/province [70] 0 0
Llantrisant
Country [71] 0 0
United Kingdom
State/province [71] 0 0
London
Country [72] 0 0
United Kingdom
State/province [72] 0 0
Newcastle
Country [73] 0 0
United Kingdom
State/province [73] 0 0
Northampton
Country [74] 0 0
United Kingdom
State/province [74] 0 0
Norwich
Country [75] 0 0
United Kingdom
State/province [75] 0 0
Nottingham
Country [76] 0 0
United Kingdom
State/province [76] 0 0
Oxford
Country [77] 0 0
United Kingdom
State/province [77] 0 0
Sheffield
Country [78] 0 0
United Kingdom
State/province [78] 0 0
Sidcup
Country [79] 0 0
United Kingdom
State/province [79] 0 0
Stevenage
Country [80] 0 0
United Kingdom
State/province [80] 0 0
Taunton
Country [81] 0 0
United Kingdom
State/province [81] 0 0
York

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Novo Nordisk A/S
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The aim of this trial is to evaluate the efficacy and safety of insulin detemir using the
2400 nmol/mL formulation to optimise dosing in subjects with type 1 diabetes on a basal (once
daily)-bolus regimen.
Trial website
https://clinicaltrials.gov/ct2/show/NCT03220425
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT03220425